HomeOpen Access NewsHealthcare Research

Healthcare Research

The cost of ignoring lung health research needs

Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.

Blockchains, trust and power: Governance models of the future

Sari Stenfors, PhD from the ReCon Blockchain Research Project at Aalto University looks at how distributed and open technologies transform our interactions In a forward-looking...

Ground-breaking results for Huntington’s Disease (HD) research

Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD)...

Pernicious Anaemia: The world’s forgotten disease

Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease From the...

The Finnish Allergy Programme 2008-2018: Reducing the burden of allergy in both patients and society

Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to...

RELEVANCE of red blood cells and why do we care about them

Anna Bogdanova from University of Zurich lifts the lid on the vital role of red blood cells in keeping the human brain running and...

Report reveals flaws and human rights challenges in European mental health systems

Mental Health Europe and the University of Kent-Tizard Centre have launched a new report which has revealed the flaws and human rights challenges in...

Chronic kidney disease – advancing opportunities for personalised treatment

Cecilia Van Cauwenberghe from Frost & Sullivan explores advancing opportunities for personalised treatment of chronic kidney disease (CKD) and research into membranous nephropathy (MN) According...

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are...

Improving the health and wealth of the UK through research

The National Institute for Health Research (NIHR) aims to improve both the health and wealth of the UK by means of research, as Open...

Could the new public health professional please stand up?

EUPHA Executive Director, Dineke Zeegers Paget explores the importance of improving public health in Europe The European Public Health Association – EUPHA – is an...

Can leisure centres hold the key to success for rehabilitation?

Ellen Rowles from Action PR highlights how local community leisure centres play a key role in rehabilitation and ease the burden on GPs A growing...

Now is the time to finally prioritise lung cancer

CEO of Roy Castle Lung Cancer Foundation, Paula Chadwick, explains why it is now the time to finally prioritise lung health The events of Tuesday...

Allergic rhinitis is scary, but health is around the corner

Roberta Savli from EFA provides insight into allergic rhinitis Rhinitis is a very common disorder, far more than just sneezing a couple of days in...

Lymphoma – what’s that?

Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every...

Millions of UK adults have never had their hearing checked

Research by Oticon reveals three quarters of UK adults have never had their hearing checked by a hearing professional, putting it at risk every...

Positive progress for people with Parkinson’s

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders